Clinical Data Management Services Tender

Clinical Data Management Services Tender

The services are clinical data management for linked health data including data cleaning.

United Kingdom-London: Data preparation services

2015/S 007-008006

Contract notice

Services

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Genomics England Limited
Charterhouse Square
Contact point(s): Genomics England Limited, Charterhouse Square, London EC1M 6BQ
For the attention of: dr. Paul Sergeant
EC1M 6BQ London
UNITED KINGDOM
E-mail: paul.sergeant@genomicsengland.co.uk

Internet address(es):

General address of the contracting authority: http://www.genomicsengland.co.uk/

Address of the buyer profile: http://www.genomicsengland.co.uk/about-genomics-england/

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority

Body governed by public law

I.3)Main activity

Health

I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: no

Section II: Object of the contract

II.1)Description

II.1.1)Title attributed to the contract by the contracting authority:

Clinical Data Management Services.

II.1.2)Type of contract and location of works, place of delivery or of performance

Services
Service category No 7: Computer and related services
Main site or location of works, place of delivery or of performance: United Kingdom.
NUTS code

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves a public contract
II.1.4)Information on framework agreement

II.1.5)Short description of the contract or purchase(s)

The services are clinical data management for linked health data including data cleaning. The clinical focus is on patients with rare diseases and cancers (breast, lung, colonic, ovarian, prostrate and blood cancers). The required services include reviewing clinical data from Genetic Medical Centres (GMCs) for completeness, consistency and quality to specified data models, definitions and NHS data standards.
The service provider will need to manage follow up with Genomic Medical Centres (GMCs) to address omissions, inconsistencies and non-standardized data. The tasks include secure management and handling of patient data.
Ideally, this work will be performed through access to the Genomics England secure data facilities.

II.1.6)Common procurement vocabulary (CPV)

72312100

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes

II.1.8)Lots

This contract is divided into lots: no

II.1.9)Information about variants

Variants will be accepted: no
II.2)Quantity or scope of the contract

II.2.1)Total quantity or scope:

See section II.1.5.
Estimated value excluding VAT:
Range: between 250 000 and 350 000 GBP

II.2.2)Information about options

Options: no

II.2.3)Information about renewals

This contract is subject to renewal: yes
Number of possible renewals: Range: between 1 and 2

II.3)Duration of the contract or time limit for completion

Starting 1.3.2015. Completion 29.2.2016

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract

III.1.1)Deposits and guarantees required:

The Company’s particular requirements will be set out in the Invitation to Tender documentation and may include, inter alia, performance bond(s) and/or parent-company guarantee(s) and/or other forms of security.

III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

Further details will be set out in the Invitation to Tender documentation.

III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

The particular requirements will be further specified, but where a consortium or other grouping of suppliers submits a bid, such consortia or grouping must nominate a lead organisation to deal with the Company on all matters relating to the Contract. All consortium members or grouping will be required to be jointly and severally liable in respect of the obligations and liabilities relating to the Contract.
III.1.4)Other particular conditions
III.2)Conditions for participation

III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: Candidates will be assessed in accordance with Part 4 of the Public Contracts Regulations 2006, as amended, (implementing Title II, Chapter VII Section 2 of Directive 2004/18/EC) on the basis of information provided in response to a Pre Qualification Questionnaire (PQQ). Copies of the PQQ are available on request from Genomics England Ltd (see I.1). Completed PQQs must be returned to the Company at the address in Section I.1 before the deadline specified in Section IV.3.4.

III.2.2)Economic and financial ability

Information and formalities necessary for evaluating if the requirements are met: See PQQ.

III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
See PQQ.
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts

III.3.1)Information about a particular profession

Execution of the service is reserved to a particular profession: no

III.3.2)Staff responsible for the execution of the service

Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: no

Section IV: Procedure

IV.1)Type of procedure

IV.1.1)Type of procedure

Accelerated restricted
Justification for the choice of accelerated procedure: The Company has now gathered sufficient information from external sources to serve as a clear and fair basis for tenders. For operational reasons — in particular, interaction with other active subsystems — the services described here are required urgently. Therefore, the tender is being conducted under the Accelerated Restricted process defined for these circumstances.

IV.1.2)Limitations on the number of operators who will be invited to tender or to participate

Envisaged minimum number 3: and maximum number 6
Objective criteria for choosing the limited number of candidates: The Company intends to invite between 3 and 6 candidates to tender on the basis of the ranking of candidates at the qualification / PQQ evaluation stage at which the criteria referred to in Part 4 of the Public Contracts Regulations 2006, as amended (implementing articles 45-52 inclusive of Directive 2004/18/EC) will be assessed and marked.
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria

IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document

IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:

IV.3.2)Previous publication(s) concerning the same contract

Prior information notice

Notice number in the OJEU: 2014/S 239-420785 of 11.12.2014

IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document

Payable documents: no

IV.3.4)Time limit for receipt of tenders or requests to participate

4.2.2015 – 17:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates

IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about European Union funds

The contract is related to a project and/or programme financed by European Union funds: no

VI.3)Additional information

Genomics England expressly reserves the rights:
i) Not to award any contract as a result of this procurement process commenced by publication of this notice;
ii) To make whatever changes it may see fit to the content and structure of the tendering competition;
iii) To award (a) contract(s) in respect of any part(s) of the services covered by this notice; and;
iv) To award contract(s) in stages.
And in no circumstances will the Company be liable for any costs incurred by candidates.
VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures

VI.4.2)Lodging of appeals

Precise information on deadline(s) for lodging appeals: Genomics England will incorporate a minimum 10 calendar day standstill period at the point that information on the award of the contract is communicated to tenderers. If an appeal regarding the award of contract has not been successfully resolved then the Public Contracts Regulations 2006 provide for aggrieved parties who have been harmed or are at risk of harm by breach of the rules to take action in the High Court. Any such action must be brought promptly (generally within 30 days).
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:

8.1.2015

Enjoyed this post? Share it!